In the past decade there have been remarkable advances in the field of pain management, from a better understanding of the basic sciences to the mechanisms of pain, to state-of-the-art drug delivery systems and formulations. Most recently, emerging research suggests new advances with novel pharmacologic modalities. Some clinicians are often ill prepared to effectively assess pain and monitor the physiological consequences of suboptimal or excessive analgesia. This can lead to inadequate pain control, adverse effects of analgesia further complicating management, or, the other extreme, overmedication that can result in serious consequences and risks for patient safety.
New research has shown a correlation between unresolved acute pain experiences and the development of chronic pain attributed to neuroplasticity. This educational activity will focus on the neurobiology of pain and it will explore the latest research and developments in the science of pain, analgesia, and the clinical implications of this emerging data. The program is developed in a highly interactive, cased-based, continuous assessment format.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Penn State College of Medicine and Rockpointe. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This Activity is supported by an educational grant from PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. |